Trial Profile
Efficacy of telaprevir after bitherapy in non-responders patients with hepatitis c.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Dec 2015
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary) ; Peginterferon; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 02 Dec 2015 New trial record